Paul J Hastings insider trades
Paul J Hastings has filed 27 Form 4s with the SEC that we hold, for Nkarta, Inc. (NKTX) (Chief Executive Officer, Director), Pacira BioSciences, Inc. (PCRX) (Director) and enGene Therapeutics Inc. (ENGN) (Director). Across all of them we count 0 purchases worth $0 and 17 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($58.7K). The largest single trade was a sale of 23,376 shares of Nkarta, Inc. worth $304.6K, dated 2022-09-28. The first filing on our record is dated 2021-10-01 and the latest 2026-06-22.
Nkarta, Inc. (NKTX)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-09-29 | S, sale reported on Form 4 | 8,277 | $225.1K | 2021-10-01 | SEC |
| 2021-09-29 | S, sale reported on Form 4 | 223 | $5.9K | 2021-10-01 | SEC |
| 2022-09-21 | S, sale reported on Form 4 | 6,126 | $79.7K | 2022-09-22 | SEC |
| 2022-09-28 | S, sale reported on Form 4 | 23,376 | $304.6K | 2022-09-30 | SEC |
| 2022-09-29 | S, sale reported on Form 4 | 498 | $6.5K | 2022-09-30 | SEC |
| 2023-01-17 | S, sale reported on Form 4 | 3,691 | $20.3K | 2023-01-18 | SEC |
| 2023-06-20 | S, sale reported on Form 4 | 1,704 | $8.3K | 2023-06-22 | SEC |
| 2024-01-16 | S, sale reported on Form 4 | 9,697 | $84.8K | 2024-01-18 | SEC |
| 2024-06-18 | S, sale reported on Form 4 | 1,770 | $9.9K | 2024-06-20 | SEC |
| 2025-01-15 | S, sale reported on Form 4 | 17,378 | $38.2K | 2025-01-17 | SEC |
| 2025-06-18 | S, sale reported on Form 4 | 1,790 | $3.2K | 2025-06-20 | SEC |
| 2026-01-15 | S, sale reported on Form 4 | 26,046 | $53.9K | 2026-01-20 | SEC |
| 2026-06-18 | S, sale reported on Form 4 | 1,776 | $4.8K | 2026-06-22 | SEC |
Pacira BioSciences, Inc. (PCRX)
enGene Therapeutics Inc. (ENGN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1309702) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
